Ministerio de Ciencia e Innovación

Programas de Investigación

Bioengineering and Medical Imaging Programme

  • A.1. Multimodal Diagnosis
    • A.1.1 Medical images

    • A.1.2 Biomedical signals

    • A.1.3 Morphological and functional modelling of tissues and organs.

    • A.1.4 Pre-operative and intra-operative planning as, well as creation of virtual surgery programs.

  • A.2. Intelligent Devices and Biomedical Systems
    • A.2.1 Creation of systems to monitor and control patients (sensoring, controlling and robotic systems)

    • A.2.2 Software applications to improve systems for patient diagnosis, monitoring or treatment

    • A.2.3 E-health and M-health Systems.

    • A.2.4 Artificial Intelligence applied to biomedical systems

Biomaterials and Advanced Therapies Programme

  • B.1 Biomaterials
    • B.1.1 Biomaterials for scaffolds

    • B.1.2 Controlled release

    • B.1.3 Bioactive nanoparticles

    • B.1.4 Cell-biomaterial interactions

    • B.1.5 Advanced manufacturing techniques (electrospinning, 3D/4D bioprinting,...)

  • B.2 Advanced Therapies
    • B.2.1 Cell therapy

    • B.2.2 Gene therapy

    • B.2.3 Tissue engineering

    • B.2.4 Stem cell differentiation and organoid culture

    • B.2.5 Directed genome edition

  • B.3. Nanobiotechnology

    • B.3.1 Biological processes research (physiology, cell adhesion or communication, cell biophysics and epigenetic) and development of techniques for their study.

Nanomedicine Programme

  • C.1. Nanodiagnosis
    • C.1.1 Biosensor devices based on micro/nanotechnologies to detect specific biomarkers of disease.

    • C.1.2 Imaging contrast agents

    • C.1.3 Precision personalized medicine

  • C.2. Therapeutic nanosystems
    • C.2.1 Biomolecules (enzymes, proteins, nucleic acids, antibodies, etc) and biomolecule-based conjugates as therapeutic agents and in applications for diagnosis.

    • C.2.2 Advanced nanoparticles for the delivery of drugs and biomolecules.

    • C.2.3 Pharmacokinetics and pharmacodynamic studies of therapeutic agents.

    • C.2.4. Theranostic systems.

  • C.3. Nanobiotechnology
    • C.3.1 Biocompatibility and toxicity studies of therapeutic agents.

    • C.3.2 Biological processes research (physiology, cell adhesion or communication, cell biophysics and epigenetic) and development of techniques for their study.